P. J. Lachmann

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Alun Davies, David L. Simmons, G Hale et al. · The Journal of Experimental Medicine · 1989 · 639 citations · Full text

Immunohematology, Cd59 Antigen, Laboratory Immunology +19

Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.

G D Ross, William J. Yount, Mark Walport et al. · The Journal of Immunology · 1985 · 300 citations

REACTIVE LYSIS: THE COMPLEMENT-MEDIATED LYSIS OF UNSENSITIZED CELLS

P. J. Lachmann, R. A. Thompson · The Journal of Experimental Medicine · 1970 · 271 citations · Full text

Immunology, Molecular Biology, Reactive Lysis +17

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures

Sheena McHugh, Ian R. Rifkin, John Deighton et al. · Clinical & Experimental Immunology · 1995 · 263 citations

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

Mark Wing, T. Moreau, Judith Greenwood et al. · Journal of Clinical Investigation · 1996 · 254 citations · Full text

First-dose Cytokine-release Syndrome, Immunology, Immune Regulation +17